Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
Manzoor, Saika
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study. [electronic resource] - Scientific reports 07 2019 - 10182 p. digital
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-019-46644-4 doi
Adult
Body Mass Index
Coagulation Protein Disorders--etiology
Contraceptives, Oral--adverse effects
Ethinyl Estradiol--therapeutic use
Female
Humans
India
Inflammation--etiology
Insulin--therapeutic use
Insulin Resistance
Levonorgestrel--therapeutic use
Metformin--administration & dosage
Polycystic Ovary Syndrome--blood
Risk Factors
Waist-Hip Ratio
Young Adult
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study. [electronic resource] - Scientific reports 07 2019 - 10182 p. digital
Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
2045-2322
10.1038/s41598-019-46644-4 doi
Adult
Body Mass Index
Coagulation Protein Disorders--etiology
Contraceptives, Oral--adverse effects
Ethinyl Estradiol--therapeutic use
Female
Humans
India
Inflammation--etiology
Insulin--therapeutic use
Insulin Resistance
Levonorgestrel--therapeutic use
Metformin--administration & dosage
Polycystic Ovary Syndrome--blood
Risk Factors
Waist-Hip Ratio
Young Adult